The global market for Recombinant Monoclonal Antibody was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.

North American market for Recombinant Monoclonal Antibody is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Recombinant Monoclonal Antibody is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global manufacturers of Recombinant Monoclonal Antibody include Abcam, Boster Bio, Evitria, Novus Biologicals, ACROBiosystems, Abyntek Biopharma, Sino Biological, Enzo Life Sciences, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Recombinant Monoclonal Antibody, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Recombinant Monoclonal Antibody.

The Recombinant Monoclonal Antibody market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Recombinant Monoclonal Antibody market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Recombinant Monoclonal Antibody manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Recombinant Monoclonal Antibody Market Report

Report Metric	Details
Report Name	Recombinant Monoclonal Antibody Market
Segment by Type	Humanized Antibodies Small Molecule Antibody Other
Segment by Application	Immunohistochemistry Western Blot Immunofluorescence Other
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	Abcam, Boster Bio, Evitria, Novus Biologicals, ACROBiosystems, Abyntek Biopharma, Sino Biological, Enzo Life Sciences
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Recombinant Monoclonal Antibody manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Recombinant Monoclonal Antibody in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Recombinant Monoclonal Antibody Market report?

Ans: The main players in the Recombinant Monoclonal Antibody Market are Abcam, Boster Bio, Evitria, Novus Biologicals, ACROBiosystems, Abyntek Biopharma, Sino Biological, Enzo Life Sciences

What are the Application segmentation covered in the Recombinant Monoclonal Antibody Market report?

Ans: The Applications covered in the Recombinant Monoclonal Antibody Market report are Immunohistochemistry, Western Blot, Immunofluorescence, Other

What are the Type segmentation covered in the Recombinant Monoclonal Antibody Market report?

Ans: The Types covered in the Recombinant Monoclonal Antibody Market report are Humanized Antibodies, Small Molecule Antibody, Other

1 Recombinant Monoclonal Antibody Market Overview

1.1 Product Definition

1.2 Recombinant Monoclonal Antibody by Type

1.2.1 Global Recombinant Monoclonal Antibody Market Value Comparison by Type (2024 VS 2031)

1.2.2 Humanized Antibodies

1.2.3 Small Molecule Antibody

1.2.4 Other

1.3 Recombinant Monoclonal Antibody by Application

1.3.1 Global Recombinant Monoclonal Antibody Market Value by Application (2024 VS 2031)

1.3.2 Immunohistochemistry

1.3.3 Western Blot

1.3.4 Immunofluorescence

1.3.5 Other

1.4 Global Recombinant Monoclonal Antibody Market Size Estimates and Forecasts

1.4.1 Global Recombinant Monoclonal Antibody Revenue 2020-2031

1.4.2 Global Recombinant Monoclonal Antibody Sales 2020-2031

1.4.3 Global Recombinant Monoclonal Antibody Market Average Price (2020-2031)

1.5 Assumptions and Limitations

2 Recombinant Monoclonal Antibody Market Competition by Manufacturers

2.1 Global Recombinant Monoclonal Antibody Sales Market Share by Manufacturers (2020-2025)

2.2 Global Recombinant Monoclonal Antibody Revenue Market Share by Manufacturers (2020-2025)

2.3 Global Recombinant Monoclonal Antibody Average Price by Manufacturers (2020-2025)

2.4 Global Key Players of Recombinant Monoclonal Antibody, Industry Ranking, 2022 VS 2023 VS 2024

2.5 Global Key Manufacturers of Recombinant Monoclonal Antibody, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Recombinant Monoclonal Antibody, Product Type & Application

2.7 Global Key Manufacturers of Recombinant Monoclonal Antibody, Date of Enter into This Industry

2.8 Global Recombinant Monoclonal Antibody Market Competitive Situation and Trends

2.8.1 Global Recombinant Monoclonal Antibody Market Concentration Rate

2.8.2 The Global 5 and 10 Largest Recombinant Monoclonal Antibody Players Market Share by Revenue

2.8.3 Global Recombinant Monoclonal Antibody Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

2.9 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Global Recombinant Monoclonal Antibody Market Scenario by Region

3.1 Global Recombinant Monoclonal Antibody Market Size by Region: 2020 Versus 2024 Versus 2031

3.2 Global Recombinant Monoclonal Antibody Sales by Region: 2020-2031

3.2.1 Global Recombinant Monoclonal Antibody Sales by Region: 2020-2025

3.2.2 Global Recombinant Monoclonal Antibody Sales by Region: 2026-2031

3.3 Global Recombinant Monoclonal Antibody Revenue by Region: 2020-2031

3.3.1 Global Recombinant Monoclonal Antibody Revenue by Region: 2020-2025

3.3.2 Global Recombinant Monoclonal Antibody Revenue by Region: 2026-2031

3.4 North America Recombinant Monoclonal Antibody Market Facts & Figures by Country

3.4.1 North America Recombinant Monoclonal Antibody Market Size by Country: 2020 VS 2024 VS 2031

3.4.2 North America Recombinant Monoclonal Antibody Sales by Country (2020-2031)

3.4.3 North America Recombinant Monoclonal Antibody Revenue by Country (2020-2031)

3.4.4 United States

3.4.5 Canada

3.5 Europe Recombinant Monoclonal Antibody Market Facts & Figures by Country

3.5.1 Europe Recombinant Monoclonal Antibody Market Size by Country: 2020 VS 2024 VS 2031

3.5.2 Europe Recombinant Monoclonal Antibody Sales by Country (2020-2031)

3.5.3 Europe Recombinant Monoclonal Antibody Revenue by Country (2020-2031)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Recombinant Monoclonal Antibody Market Facts & Figures by Region

3.6.1 Asia Pacific Recombinant Monoclonal Antibody Market Size by Region: 2020 VS 2024 VS 2031

3.6.2 Asia Pacific Recombinant Monoclonal Antibody Sales by Region (2020-2031)

3.6.3 Asia Pacific Recombinant Monoclonal Antibody Revenue by Region (2020-2031)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 China Taiwan

3.6.10 Southeast Asia

3.7 Latin America Recombinant Monoclonal Antibody Market Facts & Figures by Country

3.7.1 Latin America Recombinant Monoclonal Antibody Market Size by Country: 2020 VS 2024 VS 2031

3.7.2 Latin America Recombinant Monoclonal Antibody Sales by Country (2020-2031)

3.7.3 Latin America Recombinant Monoclonal Antibody Revenue by Country (2020-2031)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.8 Middle East and Africa Recombinant Monoclonal Antibody Market Facts & Figures by Country

3.8.1 Middle East and Africa Recombinant Monoclonal Antibody Market Size by Country: 2020 VS 2024 VS 2031

3.8.2 Middle East and Africa Recombinant Monoclonal Antibody Sales by Country (2020-2031)

3.8.3 Middle East and Africa Recombinant Monoclonal Antibody Revenue by Country (2020-2031)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 UAE

4 Segment by Type

4.1 Global Recombinant Monoclonal Antibody Sales by Type (2020-2031)

4.1.1 Global Recombinant Monoclonal Antibody Sales by Type (2020-2025)

4.1.2 Global Recombinant Monoclonal Antibody Sales by Type (2026-2031)

4.1.3 Global Recombinant Monoclonal Antibody Sales Market Share by Type (2020-2031)

4.2 Global Recombinant Monoclonal Antibody Revenue by Type (2020-2031)

4.2.1 Global Recombinant Monoclonal Antibody Revenue by Type (2020-2025)

4.2.2 Global Recombinant Monoclonal Antibody Revenue by Type (2026-2031)

4.2.3 Global Recombinant Monoclonal Antibody Revenue Market Share by Type (2020-2031)

4.3 Global Recombinant Monoclonal Antibody Price by Type (2020-2031)

5 Segment by Application

5.1 Global Recombinant Monoclonal Antibody Sales by Application (2020-2031)

5.1.1 Global Recombinant Monoclonal Antibody Sales by Application (2020-2025)

5.1.2 Global Recombinant Monoclonal Antibody Sales by Application (2026-2031)

5.1.3 Global Recombinant Monoclonal Antibody Sales Market Share by Application (2020-2031)

5.2 Global Recombinant Monoclonal Antibody Revenue by Application (2020-2031)

5.2.1 Global Recombinant Monoclonal Antibody Revenue by Application (2020-2025)

5.2.2 Global Recombinant Monoclonal Antibody Revenue by Application (2026-2031)

5.2.3 Global Recombinant Monoclonal Antibody Revenue Market Share by Application (2020-2031)

5.3 Global Recombinant Monoclonal Antibody Price by Application (2020-2031)

6 Key Companies Profiled

6.1 Abcam

6.1.1 Abcam Company Information

6.1.2 Abcam Description and Business Overview

6.1.3 Abcam Recombinant Monoclonal Antibody Sales, Revenue and Gross Margin (2020-2025)

6.1.4 Abcam Recombinant Monoclonal Antibody Product Portfolio

6.1.5 Abcam Recent Developments/Updates

6.2 Boster Bio

6.2.1 Boster Bio Company Information

6.2.2 Boster Bio Description and Business Overview

6.2.3 Boster Bio Recombinant Monoclonal Antibody Sales, Revenue and Gross Margin (2020-2025)

6.2.4 Boster Bio Recombinant Monoclonal Antibody Product Portfolio

6.2.5 Boster Bio Recent Developments/Updates

6.3 Evitria

6.3.1 Evitria Company Information

6.3.2 Evitria Description and Business Overview

6.3.3 Evitria Recombinant Monoclonal Antibody Sales, Revenue and Gross Margin (2020-2025)

6.3.4 Evitria Recombinant Monoclonal Antibody Product Portfolio

6.3.5 Evitria Recent Developments/Updates

6.4 Novus Biologicals

6.4.1 Novus Biologicals Company Information

6.4.2 Novus Biologicals Description and Business Overview

6.4.3 Novus Biologicals Recombinant Monoclonal Antibody Sales, Revenue and Gross Margin (2020-2025)

6.4.4 Novus Biologicals Recombinant Monoclonal Antibody Product Portfolio

6.4.5 Novus Biologicals Recent Developments/Updates

6.5 ACROBiosystems

6.5.1 ACROBiosystems Company Information

6.5.2 ACROBiosystems Description and Business Overview

6.5.3 ACROBiosystems Recombinant Monoclonal Antibody Sales, Revenue and Gross Margin (2020-2025)

6.5.4 ACROBiosystems Recombinant Monoclonal Antibody Product Portfolio

6.5.5 ACROBiosystems Recent Developments/Updates

6.6 Abyntek Biopharma

6.6.1 Abyntek Biopharma Company Information

6.6.2 Abyntek Biopharma Description and Business Overview

6.6.3 Abyntek Biopharma Recombinant Monoclonal Antibody Sales, Revenue and Gross Margin (2020-2025)

6.6.4 Abyntek Biopharma Recombinant Monoclonal Antibody Product Portfolio

6.6.5 Abyntek Biopharma Recent Developments/Updates

6.7 Sino Biological

6.7.1 Sino Biological Company Information

6.7.2 Sino Biological Description and Business Overview

6.7.3 Sino Biological Recombinant Monoclonal Antibody Sales, Revenue and Gross Margin (2020-2025)

6.7.4 Sino Biological Recombinant Monoclonal Antibody Product Portfolio

6.7.5 Sino Biological Recent Developments/Updates

6.8 Enzo Life Sciences

6.8.1 Enzo Life Sciences Company Information

6.8.2 Enzo Life Sciences Description and Business Overview

6.8.3 Enzo Life Sciences Recombinant Monoclonal Antibody Sales, Revenue and Gross Margin (2020-2025)

6.8.4 Enzo Life Sciences Recombinant Monoclonal Antibody Product Portfolio

6.8.5 Enzo Life Sciences Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Recombinant Monoclonal Antibody Industry Chain Analysis

7.2 Recombinant Monoclonal Antibody Raw Material Supply Analysis

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Recombinant Monoclonal Antibody Production Mode & Process Analysis

7.4 Recombinant Monoclonal Antibody Sales and Marketing

7.4.1 Recombinant Monoclonal Antibody Sales Channels

7.4.2 Recombinant Monoclonal Antibody Distributors

7.5 Recombinant Monoclonal Antibody Customer Analysis

8 Recombinant Monoclonal Antibody Market Dynamics

8.1 Recombinant Monoclonal Antibody Industry Trends

8.2 Recombinant Monoclonal Antibody Market Drivers

8.3 Recombinant Monoclonal Antibody Market Challenges

8.4 Recombinant Monoclonal Antibody Market Restraints

9 Research Findings and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

List of Tables

Table 1. Global Recombinant Monoclonal Antibody Market Value Comparison by Type (2024 VS 2031) & (US$ Million)

Table 2. Global Recombinant Monoclonal Antibody Market Value by Application (2024 VS 2031) & (US$ Million)

Table 3. Global Recombinant Monoclonal Antibody Market Competitive Situation by Manufacturers in 2024

Table 4. Global Recombinant Monoclonal Antibody Sales (K Units) of Key Manufacturers (2020-2025)

Table 5. Global Recombinant Monoclonal Antibody Sales Market Share by Manufacturers (2020-2025)

Table 6. Global Recombinant Monoclonal Antibody Revenue (US$ Million) by Manufacturers (2020-2025)

Table 7. Global Recombinant Monoclonal Antibody Revenue Share by Manufacturers (2020-2025)

Table 8. Global Market Recombinant Monoclonal Antibody Average Price (US$/Unit) of Key Manufacturers (2020-2025)

Table 9. Global Key Players of Recombinant Monoclonal Antibody, Industry Ranking, 2022 VS 2023 VS 2024

Table 10. Global Key Manufacturers of Recombinant Monoclonal Antibody, Manufacturing Sites & Headquarters

Table 11. Global Key Manufacturers of Recombinant Monoclonal Antibody, Product Type & Application

Table 12. Global Key Manufacturers of Recombinant Monoclonal Antibody, Date of Enter into This Industry

Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Recombinant Monoclonal Antibody by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Recombinant Monoclonal Antibody as of 2024)

Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 16. Global Recombinant Monoclonal Antibody Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 17. Global Recombinant Monoclonal Antibody Sales by Region (2020-2025) & (K Units)

Table 18. Global Recombinant Monoclonal Antibody Sales Market Share by Region (2020-2025)

Table 19. Global Recombinant Monoclonal Antibody Sales by Region (2026-2031) & (K Units)

Table 20. Global Recombinant Monoclonal Antibody Sales Market Share by Region (2026-2031)

Table 21. Global Recombinant Monoclonal Antibody Revenue by Region (2020-2025) & (US$ Million)

Table 22. Global Recombinant Monoclonal Antibody Revenue Market Share by Region (2020-2025)

Table 23. Global Recombinant Monoclonal Antibody Revenue by Region (2026-2031) & (US$ Million)

Table 24. Global Recombinant Monoclonal Antibody Revenue Market Share by Region (2026-2031)

Table 25. North America Recombinant Monoclonal Antibody Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 26. North America Recombinant Monoclonal Antibody Sales by Country (2020-2025) & (K Units)

Table 27. North America Recombinant Monoclonal Antibody Sales by Country (2026-2031) & (K Units)

Table 28. North America Recombinant Monoclonal Antibody Revenue by Country (2020-2025) & (US$ Million)

Table 29. North America Recombinant Monoclonal Antibody Revenue by Country (2026-2031) & (US$ Million)

Table 30. Europe Recombinant Monoclonal Antibody Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 31. Europe Recombinant Monoclonal Antibody Sales by Country (2020-2025) & (K Units)

Table 32. Europe Recombinant Monoclonal Antibody Sales by Country (2026-2031) & (K Units)

Table 33. Europe Recombinant Monoclonal Antibody Revenue by Country (2020-2025) & (US$ Million)

Table 34. Europe Recombinant Monoclonal Antibody Revenue by Country (2026-2031) & (US$ Million)

Table 35. Asia Pacific Recombinant Monoclonal Antibody Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 36. Asia Pacific Recombinant Monoclonal Antibody Sales by Region (2020-2025) & (K Units)

Table 37. Asia Pacific Recombinant Monoclonal Antibody Sales by Region (2026-2031) & (K Units)

Table 38. Asia Pacific Recombinant Monoclonal Antibody Revenue by Region (2020-2025) & (US$ Million)

Table 39. Asia Pacific Recombinant Monoclonal Antibody Revenue by Region (2026-2031) & (US$ Million)

Table 40. Latin America Recombinant Monoclonal Antibody Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 41. Latin America Recombinant Monoclonal Antibody Sales by Country (2020-2025) & (K Units)

Table 42. Latin America Recombinant Monoclonal Antibody Sales by Country (2026-2031) & (K Units)

Table 43. Latin America Recombinant Monoclonal Antibody Revenue by Country (2020-2025) & (US$ Million)

Table 44. Latin America Recombinant Monoclonal Antibody Revenue by Country (2026-2031) & (US$ Million)

Table 45. Middle East and Africa Recombinant Monoclonal Antibody Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 46. Middle East and Africa Recombinant Monoclonal Antibody Sales by Country (2020-2025) & (K Units)

Table 47. Middle East and Africa Recombinant Monoclonal Antibody Sales by Country (2026-2031) & (K Units)

Table 48. Middle East and Africa Recombinant Monoclonal Antibody Revenue by Country (2020-2025) & (US$ Million)

Table 49. Middle East and Africa Recombinant Monoclonal Antibody Revenue by Country (2026-2031) & (US$ Million)

Table 50. Global Recombinant Monoclonal Antibody Sales (K Units) by Type (2020-2025)

Table 51. Global Recombinant Monoclonal Antibody Sales (K Units) by Type (2026-2031)

Table 52. Global Recombinant Monoclonal Antibody Sales Market Share by Type (2020-2025)

Table 53. Global Recombinant Monoclonal Antibody Sales Market Share by Type (2026-2031)

Table 54. Global Recombinant Monoclonal Antibody Revenue (US$ Million) by Type (2020-2025)

Table 55. Global Recombinant Monoclonal Antibody Revenue (US$ Million) by Type (2026-2031)

Table 56. Global Recombinant Monoclonal Antibody Revenue Market Share by Type (2020-2025)

Table 57. Global Recombinant Monoclonal Antibody Revenue Market Share by Type (2026-2031)

Table 58. Global Recombinant Monoclonal Antibody Price (US$/Unit) by Type (2020-2025)

Table 59. Global Recombinant Monoclonal Antibody Price (US$/Unit) by Type (2026-2031)

Table 60. Global Recombinant Monoclonal Antibody Sales (K Units) by Application (2020-2025)

Table 61. Global Recombinant Monoclonal Antibody Sales (K Units) by Application (2026-2031)

Table 62. Global Recombinant Monoclonal Antibody Sales Market Share by Application (2020-2025)

Table 63. Global Recombinant Monoclonal Antibody Sales Market Share by Application (2026-2031)

Table 64. Global Recombinant Monoclonal Antibody Revenue (US$ Million) by Application (2020-2025)

Table 65. Global Recombinant Monoclonal Antibody Revenue (US$ Million) by Application (2026-2031)

Table 66. Global Recombinant Monoclonal Antibody Revenue Market Share by Application (2020-2025)

Table 67. Global Recombinant Monoclonal Antibody Revenue Market Share by Application (2026-2031)

Table 68. Global Recombinant Monoclonal Antibody Price (US$/Unit) by Application (2020-2025)

Table 69. Global Recombinant Monoclonal Antibody Price (US$/Unit) by Application (2026-2031)

Table 70. Abcam Company Information

Table 71. Abcam Description and Business Overview

Table 72. Abcam Recombinant Monoclonal Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 73. Abcam Recombinant Monoclonal Antibody Product

Table 74. Abcam Recent Developments/Updates

Table 75. Boster Bio Company Information

Table 76. Boster Bio Description and Business Overview

Table 77. Boster Bio Recombinant Monoclonal Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 78. Boster Bio Recombinant Monoclonal Antibody Product

Table 79. Boster Bio Recent Developments/Updates

Table 80. Evitria Company Information

Table 81. Evitria Description and Business Overview

Table 82. Evitria Recombinant Monoclonal Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 83. Evitria Recombinant Monoclonal Antibody Product

Table 84. Evitria Recent Developments/Updates

Table 85. Novus Biologicals Company Information

Table 86. Novus Biologicals Description and Business Overview

Table 87. Novus Biologicals Recombinant Monoclonal Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 88. Novus Biologicals Recombinant Monoclonal Antibody Product

Table 89. Novus Biologicals Recent Developments/Updates

Table 90. ACROBiosystems Company Information

Table 91. ACROBiosystems Description and Business Overview

Table 92. ACROBiosystems Recombinant Monoclonal Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 93. ACROBiosystems Recombinant Monoclonal Antibody Product

Table 94. ACROBiosystems Recent Developments/Updates

Table 95. Abyntek Biopharma Company Information

Table 96. Abyntek Biopharma Description and Business Overview

Table 97. Abyntek Biopharma Recombinant Monoclonal Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 98. Abyntek Biopharma Recombinant Monoclonal Antibody Product

Table 99. Abyntek Biopharma Recent Developments/Updates

Table 100. Sino Biological Company Information

Table 101. Sino Biological Description and Business Overview

Table 102. Sino Biological Recombinant Monoclonal Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 103. Sino Biological Recombinant Monoclonal Antibody Product

Table 104. Sino Biological Recent Developments/Updates

Table 105. Enzo Life Sciences Company Information

Table 106. Enzo Life Sciences Description and Business Overview

Table 107. Enzo Life Sciences Recombinant Monoclonal Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 108. Enzo Life Sciences Recombinant Monoclonal Antibody Product

Table 109. Enzo Life Sciences Recent Developments/Updates

Table 110. Key Raw Materials Lists

Table 111. Raw Materials Key Suppliers Lists

Table 112. Recombinant Monoclonal Antibody Distributors List

Table 113. Recombinant Monoclonal Antibody Customers List

Table 114. Recombinant Monoclonal Antibody Market Trends

Table 115. Recombinant Monoclonal Antibody Market Drivers

Table 116. Recombinant Monoclonal Antibody Market Challenges

Table 117. Recombinant Monoclonal Antibody Market Restraints

Table 118. Research Programs/Design for This Report

Table 119. Key Data Information from Secondary Sources

Table 120. Key Data Information from Primary Sources

Table 121. Authors List of This Report

List of Figures

Figure 1. Product Picture of Recombinant Monoclonal Antibody

Figure 2. Global Recombinant Monoclonal Antibody Market Value Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Recombinant Monoclonal Antibody Market Share by Type: 2024 & 2031

Figure 4. Humanized Antibodies Product Picture

Figure 5. Small Molecule Antibody Product Picture

Figure 6. Other Product Picture

Figure 7. Global Recombinant Monoclonal Antibody Market Value by Application (2020-2031) & (US$ Million)

Figure 8. Global Recombinant Monoclonal Antibody Market Share by Application: 2024 & 2031

Figure 9. Immunohistochemistry

Figure 10. Western Blot

Figure 11. Immunofluorescence

Figure 12. Other

Figure 13. Global Recombinant Monoclonal Antibody Revenue, (US$ Million), 2020 VS 2024 VS 2031

Figure 14. Global Recombinant Monoclonal Antibody Market Size (2020-2031) & (US$ Million)

Figure 15. Global Recombinant Monoclonal Antibody Sales (2020-2031) & (K Units)

Figure 16. Global Recombinant Monoclonal Antibody Average Price (US$/Unit) & (2020-2031)

Figure 17. Recombinant Monoclonal Antibody Report Years Considered

Figure 18. Recombinant Monoclonal Antibody Sales Share by Manufacturers in 2024

Figure 19. Global Recombinant Monoclonal Antibody Revenue Share by Manufacturers in 2024

Figure 20. Global 5 and 10 Largest Recombinant Monoclonal Antibody Players: Market Share by Revenue in Recombinant Monoclonal Antibody in 2024

Figure 21. Recombinant Monoclonal Antibody Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024

Figure 22. Global Recombinant Monoclonal Antibody Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Figure 23. North America Recombinant Monoclonal Antibody Sales Market Share by Country (2020-2031)

Figure 24. North America Recombinant Monoclonal Antibody Revenue Market Share by Country (2020-2031)

Figure 25. United States Recombinant Monoclonal Antibody Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 26. Canada Recombinant Monoclonal Antibody Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 27. Europe Recombinant Monoclonal Antibody Sales Market Share by Country (2020-2031)

Figure 28. Europe Recombinant Monoclonal Antibody Revenue Market Share by Country (2020-2031)

Figure 29. Germany Recombinant Monoclonal Antibody Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 30. France Recombinant Monoclonal Antibody Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 31. U.K. Recombinant Monoclonal Antibody Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 32. Italy Recombinant Monoclonal Antibody Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 33. Russia Recombinant Monoclonal Antibody Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 34. Asia Pacific Recombinant Monoclonal Antibody Sales Market Share by Region (2020-2031)

Figure 35. Asia Pacific Recombinant Monoclonal Antibody Revenue Market Share by Region (2020-2031)

Figure 36. China Recombinant Monoclonal Antibody Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 37. Japan Recombinant Monoclonal Antibody Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 38. South Korea Recombinant Monoclonal Antibody Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 39. India Recombinant Monoclonal Antibody Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 40. Australia Recombinant Monoclonal Antibody Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 41. China Taiwan Recombinant Monoclonal Antibody Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 42. Southeast Asia Recombinant Monoclonal Antibody Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 43. Latin America Recombinant Monoclonal Antibody Sales Market Share by Country (2020-2031)

Figure 44. Latin America Recombinant Monoclonal Antibody Revenue Market Share by Country (2020-2031)

Figure 45. Mexico Recombinant Monoclonal Antibody Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 46. Brazil Recombinant Monoclonal Antibody Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 47. Argentina Recombinant Monoclonal Antibody Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 48. Middle East and Africa Recombinant Monoclonal Antibody Sales Market Share by Country (2020-2031)

Figure 49. Middle East and Africa Recombinant Monoclonal Antibody Revenue Market Share by Country (2020-2031)

Figure 50. Turkey Recombinant Monoclonal Antibody Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 51. Saudi Arabia Recombinant Monoclonal Antibody Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 52. UAE Recombinant Monoclonal Antibody Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 53. Global Sales Market Share of Recombinant Monoclonal Antibody by Type (2020-2031)

Figure 54. Global Revenue Market Share of Recombinant Monoclonal Antibody by Type (2020-2031)

Figure 55. Global Recombinant Monoclonal Antibody Price (US$/Unit) by Type (2020-2031)

Figure 56. Global Sales Market Share of Recombinant Monoclonal Antibody by Application (2020-2031)

Figure 57. Global Revenue Market Share of Recombinant Monoclonal Antibody by Application (2020-2031)

Figure 58. Global Recombinant Monoclonal Antibody Price (US$/Unit) by Application (2020-2031)

Figure 59. Recombinant Monoclonal Antibody Value Chain

Figure 60. Channels of Distribution (Direct Vs Distribution)

Figure 61. Bottom-up and Top-down Approaches for This Report

Figure 62. Data Triangulation

Figure 63. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

RELATED REPORTS

Global Pharma and Healthcare Social Media Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-14Y6812

Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Food Additives Testing Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-34O3983

Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Gabapentin API Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-9V17601

Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Electronic Informed Consent Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-22C17047

Fri Sep 12 00:00:00 UTC 2025

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions